My pharm 2 exam2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/223

encourage image

There's no tags or description

Looks like no tags are added yet.

224 Terms

1
New cards

β-Lactam antibiotics: classes and shared MOA

Penicillins, cephalosporins, monobactams, carbapenems (all contain a β-lactam ring) • BACTERICIDAL • Structural analogues of D-ala-D-ala: bind and inactivate PBPs • Block transpeptidation (peptidoglycan cross-linking) • Autolysins released, then cell lysis

2
New cards

PBPs (penicillin-binding proteins)

Enzymes on the inner bacterial cell membrane • Assemble and reshape the cell wall during growth and division • Target of every β-lactam

3
New cards

Main resistance mechanism to penicillins

Bacteria make β-lactamase, which cleaves the β-lactam ring • Fixes: β-lactamase-resistant penicillins (nafcillin, oxacillin) or add an inhibitor (clavulanic acid)

4
New cards

Penicillins: advantages

Bactericidal against sensitive strains • Relatively nontoxic, excellent tissue penetration • Efficacious and inexpensive • Semisynthetic versions have a broader spectrum

5
New cards

Penicillins: disadvantages

Acid lability (some agents) • Short duration of action • Limited against gram-negatives (mainly gram-positive) • Drug hypersensitivity • Resistance when bacteria produce β-lactamase

6
New cards

Penicillin side effects

Diarrhea, nausea • Anemia • Renal toxicity • Hypersensitivity (the big one)

7
New cards

Penicillin clinical uses

Ear, nose, throat infections • Respiratory and urinary tract infections • Prostate infections • Certain sexually transmitted diseases

8
New cards

Natural penicillins

Penicillin G and Penicillin V • Pen V: ORAL, more stable in gastric acid • [+] Pen G is acid-labile, so it is given parenterally

9
New cards

Anti-staphylococcal penicillins (β-lactamase resistant)

Nafcillin, Oxacillin* • Effective against staph that produce β-lactamase • Semisynthetic; bind PBPs and stop cell wall formation

10
New cards

Amoxicillin

Semisynthetic penicillin, broader spectrum; oral (acid-stable) • Binds PBPs, stops cell wall formation • ⚠ Your notes file it under 'β-lactamase-R'. Amoxicillin is actually β-lactamase SENSITIVE, which is why it is paired with clavulanic acid (Augmentin). Check against your slides.

11
New cards

Augmentin

= Clavulanic acid + Amoxicillin • Clavulanic acid inhibits β-lactamases, protecting the β-lactam and enhancing its effectiveness

12
New cards

Cephalosporins: overview

Broad spectrum; structurally and functionally like penicillin • Use if allergic to penicillin (cross-reactivity possible) • Per notes: not affected by β-lactamase because of a large R group • Cons: allergies, thrombophlebitis, renal damage

13
New cards

Cefoxitin

Expanded spectrum of activity • Better anaerobic coverage

14
New cards

Ceftriaxone

Extended spectrum of activity • Used for meningitis and gonorrhea

15
New cards

Carbapenems: Imipenem / cilastatin

Bind PBPs, halting cell wall synthesis • β-lactamases are not effective against them • Cilastatin inhibits dehydropeptidase (renal), preventing degradation of imipenem

16
New cards

Cilastatin: role

Inhibits dehydropeptidase • Prevents breakdown of imipenem, so imipenem lasts longer

17
New cards

Monobactam: Aztreonam

Binds PBPs, halting cell wall synthesis • Gram-negative rods only • Use when allergic to penicillin

18
New cards

Daptomycin

Acts on the cell envelope by causing rapid depolarization • Good against MRSA and vancomycin-resistant organisms

19
New cards

Vancomycin: MOA

Inhibits cell wall synthesis in gram-positive bacteria by targeting D-ala-D-ala • Inhibits transglycosylase and prevents cleavage of the peptidoglycan precursor

20
New cards

Vancomycin: uses

MRSA sepsis • Endocarditis • Staph/strep infection in penicillin allergy • Severe C. diff (oral)

21
New cards

Vancomycin: administration

NOT absorbed orally, so given IV • (oral route only for C. diff, which lives in the gut)

22
New cards

Vancomycin resistance

D-ala-D-ala is changed to D-ala-D-lac, especially in enterococci (VRE; also VRSA) • Treated with a unique 3-pronged approach per notes

23
New cards

Red-neck (red-man) syndrome

Vancomycin • Histamine release causing flushing • Infusion-rate related

24
New cards

Penicillin-allergic patient: alternatives (cell wall)

Cephalosporins (with caution) • Aztreonam (gram-negative rods) • Vancomycin (staph-strep infections)

25
New cards

Ribosomal target cheat sheet

30S: tetracyclines (block tRNA at A site), aminoglycosides (misread mRNA) • 50S: macrolides (block translocation), clindamycin (block translocation), linezolid (blocks initiation complex), chloramphenicol (blocks peptidyl transferase)

26
New cards

Tetracyclines: MOA

Bind the 30S ribosomal subunit • Block binding of tRNA to the A site • Broad spectrum and BACTERIOSTATIC

27
New cards

Tetracyclines: side effects

Teeth discoloration • Renal and hepatic injury • GI upset • Photosensitive rash • Superinfections (e.g. candida vaginitis) • Antagonizes penicillin efficacy

28
New cards

Tetracyclines: who should not get them

Children under 8 years old (teeth discoloration)

29
New cards

Tetracyclines: absorption pearl

Neutralized by chelation with Ca (milk) and other divalent cations

30
New cards

Tetracyclines: uses and resistance

Lyme disease (bull's-eye rash) • Resistance: efflux pump moves drug out, or the ribosome is altered

31
New cards

Doxycycline

Zoonotic disease • Chlamydia, urethritis, PID • Bronchitis, community-acquired pneumonia

32
New cards

Aminoglycosides: MOA

Bind the 30S ribosomal subunit • Interfere with protein synthesis and cause MISREADING of mRNA • BACTERICIDAL

33
New cards

Aminoglycosides: side effects

Deafness and vestibular dysfunction (8th nerve) • Renal damage • Nausea, allergy • Neuromuscular paralysis (inhibit ACh release)

34
New cards

What blocks aminoglycoside entry into bacteria?

Anaerobiasis (anaerobic conditions) • Divalent cations • Hyperosmolarity

35
New cards

Aminoglycosides: dosing concept

Concentration-dependent killing: the higher the concentration, the faster the kill

36
New cards

Aminoglycoside members + mnemonic

Amikacin, Gentamicin, Neomycin*, Streptomycin • Mnemonic: 'Amis Neo gentleman gave her strep'

37
New cards

Streptomycin

First-line for TB (part of RIPES) • Kills gram-negatives; static after hours

38
New cards

Macrolides (-thromycin): MOA

Bind the 50S subunit • Inhibit translocation (A to P site), blocking peptide chain elongation • Bind 23S rRNA of the 50S subunit • Bacteriostatic, broad range

39
New cards

Macrolides: side effects

Hepatic injury, anemia, allergies • GI intolerance • May increase sudden death (prolonged QT, arrhythmias)

40
New cards

Why do macrolides cause GI intolerance?

They are motilin receptor AGONISTS, directly stimulating gut motility

41
New cards

Azithromycin

Wider spectrum than erythromycin • t1/2 about 55-76 hr • Does NOT inhibit CYP450 (fewer drug interactions) • Bind 23S rRNA of 50S, inhibits elongation; static but broad • Uses per notes: chlamydia, Lyme disease

42
New cards

Erythromycin

Inhibits CYP3A4, so it raises serum levels of other drugs • Binds 23S rRNA of 50S; static but broad range • Stimulates gut motility, causing GI intolerance

43
New cards

Clarithromycin

Binds 50S, inhibits CYP3A4 • QT prolongation • Bacteriostatic • Used for H. pylori

44
New cards

Clindamycin (lincosamide)

Binds 50S, blocks translocation, inhibits bacterial protein synthesis

45
New cards

Linezolid (oxazolidinone)

Binds 50S, prevents formation of the initiation complex • Gram-positive incl. MRSA and vancomycin-resistant enterococcus • Cons: thrombocytopenia, anemia, neutropenia, optic neuropathy, peripheral neuropathy, serotonin syndrome

46
New cards

Chloramphenicol

Binds 50S, inhibits peptidyl transferase (peptide bond formation) • Aplastic anemia • Gray baby syndrome

47
New cards

Quinolones: MOA

Inhibit the bacterial DNA gyrase complex, disrupting DNA processes • BACTERICIDAL • Less selective because they hit nucleic acid synthesis

48
New cards

Quinolones: toxicity

GI issues, headache, lightheadedness • Tendonitis • Potential aortic aneurysm

49
New cards

Ciprofloxacin*

Fluoroquinolone; treats ANTHRAX • Increases MMP (breaks down collagen), linked to aortic aneurysm

50
New cards

Levofloxacin*

Fluoroquinolone • Inhibits DNA gyrase + topoisomerase IV

51
New cards

Sulfasalazine

Inhibitor of folate synthesis; decreases folate •

Used in ulcerative colitis and rheumatoid arthritis

anti-inflammatory

52
New cards

Trimethoprim

Inhibitor of folate REDUCTION: blocks DHFR • Less tetrahydrofolate, so less DNA synthesis • Similar effect to methotrexate (MTX)

antibiotic for UTIs, bladder infection, traveler’s diarrhea

53
New cards

Co-trimoxazole

= Trimethoprim + sulfamethoxazole* • Combination folate pathway blockade • [+] Sulfonamide blocks folate synthesis; trimethoprim blocks DHFR (sequential block)


for Pneumocystis pneumonia for ppl w/ HIV

54
New cards

Antifungal targets (big picture)

Fungal cell membrane (ergosterol) or cell wall (β-1,3-glucan) •


Membrane: amphotericin B, nystatin (bind ergosterol); azoles; terbinafine (block ergosterol synthesis) •


Wall: caspofungin •


Nucleic acid: flucytosine

55
New cards

Amphotericin B: MOA and spectrum

Alters membrane permeability by binding ergosterol • Broad coverage; reserved for serious systemic infections (e.g. cryptococcal meningitis) • Not for dermatophytic infections

56
New cards

Amphotericin B: toxicity

Renal tubular damage • Hypokalemia • Chills and fever • Liposomal prep = safer delivery but more expensive

57
New cards

Caspofungin

Inhibits synthesis of β(1,3)-D-glucan (needed for fungal cell wall) • Active against Aspergillus and Candida • (notes say 'bacteriocidal'; it is fungicidal vs Candida)

58
New cards

Flucytosine: MOA

Prodrug related to 5-fluorouracil • Fungal cytosine deaminase converts it to 5-FU, then 5-FdUMP • Selective because fungi, not humans, do the conversion

59
New cards

Flucytosine: PK and uses

Renal elimination, crosses the BBB • Limited to cryptococcus, chromoblastomycosis, some candida • Co-administered with Amphotericin B for cryptococcal meningitis and systemic candida

60
New cards

Azoles (imidazoles and triazoles): MOA

Block demethylation of lanosterol to ergosterol by inhibiting CYP450 (14α-demethylase) • Result: no ergosterol, so a defective fungal membrane • ⚠ Notes say 'cell wall'; it is the membrane (ergosterol)

61
New cards

Fluconazole (most widely used)

Crosses the BBB • Better oral absorption; not dependent on gastric acid • Does not affect human sterol metabolism • Some drug interactions via microsomal P450 inhibition • PO, IV • NOT effective against Aspergillus

62
New cards

Fluconazole + Amphotericin B

Used together for cryptococcal meningitis

63
New cards

Fluconazole vs ketoconazole

Fluconazole: crosses BBB, better oral absorption, no effect on human sterol metabolism, not gastric-acid dependent • Ketoconazole: acidic pH needed, no BBB crossing, interferes with human sterols

64
New cards

Itraconazole*

PO, IV • Histoplasma, Blastomyces, Sporothrix • Active against Aspergillus

65
New cards

Ketoconazole*: spectrum and uses

Broad coverage but NOT active against Aspergillus • Acidic pH needed; does not cross BBB • Oral, gastro-esophageal candidiasis, histoplasmosis, blastomycosis • PO, topical

66
New cards

Ketoconazole: toxicity

Interferes with human sterol metabolism: gynecomastia; blocks gonadal and adrenal androgen synthesis; may block cortisol secretion • Hepatotoxicity • Disulfiram-like reaction (per notes)

67
New cards

Ketoconazole: drug interactions

Inhibits microsomal CYP450: raises cyclosporin and warfarin levels • Rifampin lowers keto levels and keto impairs rifampin absorption • Avoid antacids (need acid)

68
New cards

Posaconazole

PO • Active on Aspergillus • Active versus Mucormycosis (sinuses, brain, lungs)

69
New cards

Voriconazole

PO, IV • Drug of CHOICE for Aspergillus

70
New cards

Clotrimazole

Topical • Dermatophyte infections

71
New cards

Griseofulvin

Dermatophytes (ringworm) • Binds fungal microtubules, disrupting mitosis • Deposits in keratin • Causes photosensitivity

72
New cards

Nystatin

Binds ergosterol, altering membrane permeability • Treats MUCOSAL candidal infections • Side effect: mild GI disturbances

73
New cards

Terbinafine

Squalene epoxidase inhibitor: blocks ergosterol synthesis • Toxic squalene builds up, membrane permeability rises • Dermatophyte onychomycosis (nail fungus), tinea • Metabolized by CYP450; hepatic toxicity; half-life 200-400 hr • Cons: GI issues, headache, rash, liver toxicity

74
New cards

Subcutaneous vs cutaneous mycoses: drug grouping

Systemic/deep: amphotericin B, caspofungin, flucytosine, azoles (flu-, itra-, keto-, posa-, vori-conazole) • Cutaneous: clotrimazole, griseofulvin, nystatin, terbinafine

75
New cards

Aspergillus: which drugs?

Choice: voriconazole • Also active: itraconazole, posaconazole, caspofungin • NOT fluconazole or ketoconazole

76
New cards

Cryptococcal meningitis regimen

Amphotericin B + flucytosine (both cross CNS) • Fluconazole also used with Amp B

77
New cards

PRACTICE: Treatment of dermatophyte infections includes all EXCEPT: A. Terbinafine B. Clotrimazole C. Nystatin D. Fluconazole

Answer: C. Nystatin • Nystatin is for mucosal candidiasis, not dermatophytes • Dermatophyte drugs: terbinafine, clotrimazole, griseofulvin • (fluconazole has some activity but is not a nystatin-type 'mucosal only' agent; C is the intended answer)

78
New cards

Antiviral therapy: general points

Con: bone marrow suppression (granulocytopenia) • Antiretroviral: relapse if stopped • CD4 count is the main predictor • CCR5-tropic HIV-1 = sexual acquisition

79
New cards

HIV treatment (HAART)

Combination of three drugs: reverse transcriptase inhibitors, protease inhibitors, and others • Newly diagnosed: single pill Atripla = efavirenz + emtricitabine + tenofovir (3 antiretrovirals daily)

80
New cards

HIV life cycle (6 steps)

1 Attach: HIV binds CD4 • 2 Enter: virus enters cell • 3 Reverse transcribe: RNA to DNA • 4 Integrate: viral DNA joins host DNA • 5 Assemble: new immature viruses form • 6 Mature: protease makes virus infectious

81
New cards

HIV drug class by life-cycle step

Entry: enfuvirtide (gp41), maraviroc (CCR5) • Reverse transcription: NRTIs, NNRTIs • Integration: -tegravirs • Maturation: protease inhibitors (-navirs)

82
New cards

NRTIs: MOA, toxicity, spectrum

Nucleoside reverse transcriptase inhibitors compete with natural nucleosides: CHAIN TERMINATION • Toxicity: mitochondrial (lactic acidosis, hepatic steatosis) • HIV-1 and HIV-2

83
New cards

NRTI list + mnemonic

Abacavir, Emtricitabine, Lamivudine, Stavudine, Tenofovir, Zidovudine • Mnemonic from notes: AL-STEM-Z

84
New cards

NNRTIs

Efavirenz, Rilpivirine • HIV-1 ONLY (not HIV-2)

85
New cards

Protease inhibitors (-navir)

Lopinavir: HIV-1 only • Ritonavir: HIV-1 and HIV-2 • Block cleavage of GAG-POL polyprotein (maturation)

86
New cards

Enfuvirtide (fusion inhibitor)

Binds the gp41 subunit of the HIV-1 envelope glycoprotein • Prevents conformational changes needed for viral-cell membrane fusion

87
New cards

Maraviroc (CCR5 antagonist)

Blocks the CCR5 co-receptor, stopping entry of CCR5-tropic HIV-1

88
New cards

Integrase inhibitors (-tegravir)

Dolutegravir, Elvitegravir, Raltegravir • Block the strand transfer step; HIV-1 and HIV-2 • Prevent covalent bonds between viral DNA and host DNA

89
New cards

HIV fixed-dose combinations

Lamivudine + Abacavir • Emtricitabine + Tenofovir = Truvada • Zidovudine + Lamivudine • Efavirenz + Emtricitabine + Tenofovir = Atripla • Rilpivirine + Tenofovir + Emtricitabine • Zidovudine + Lamivudine + Abacavir • Elvitegravir + Cobicistat + Tenofovir + Emtricitabine

90
New cards

Amantadine: MOA and use

Influenza A: targets the M2 protein, blocking uncoating (early stage) • Prophylaxis for influenza A; treat within first 48 hr

91
New cards

Amantadine: toxicity

CNS: confusion, nervousness, insomnia, seizures, coma, trouble concentrating • Anticholinergic: blurred vision, dry mouth, palpitations • Caution in glaucoma and prostatic hypertrophy

92
New cards

Rimantadine

Influenza A, M2 blocker, prevents uncoating • Less CNS toxicity than amantadine

93
New cards

Ribavirin

Interferes with viral RNA replication • Toxicity: RBC breakdown, hemolytic anemia

94
New cards

Neuraminidase inhibitors (-amivir)

Influenza A and B • Decrease release of virus from infected cells, increase viral aggregation, decrease spread

95
New cards

Oseltamivir

About 75% effective as prophylaxis; 80% bioavailable; excreted unchanged in urine • AE: nausea, vomiting, headache

96
New cards

Zanamivir

AE: throat discomfort, bronchospasm

97
New cards

Interferon (glycoproteins)

Induces host cell enzymes that block viral protein production (inhibit translation of viral mRNA) • Uses: Kaposi's sarcoma, hairy cell leukemia, condyloma acuminata, laryngeal papillomatosis, chronic hepatitis B • AE: flu-like symptoms, BM suppression, neurotoxicity, alopecia, increased liver enzymes

98
New cards

Pegylated interferon

Longer-lasting interferon • Boosts antiviral immune response

99
New cards

Lamivudine

NRTI, chain termination • Treats HIV and hepatitis B

100
New cards

Tenofovir

NRTI used in HAART • Damages kidney and bones